Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Differences between statins on clinical endpoints: a population-based cohort study.

Jeanne P Dieleman1, Jacobus T van Wyk, Marc A M van Wijk

  • 1Department of Medical Informatics, Erasmus MC, University Medical Centre Rotterdam, The Netherlands. j.dieleman@erasmusmc.nl

Current Medical Research and Opinion
|October 4, 2005
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Systematic Review to Summarize and Critically Appraise Existing Phenotype Libraries Using Electronic Health Records.

Pharmacoepidemiology and drug safety·2026
Same author

Insights in the (patho)physiology of uterine activity in the first 30 min after childbirth.

Placenta·2026
Same author

Intrapartum cardiotocographic patterns and perinatal outcomes in extremely preterm births: an exploratory retrospective cohort study.

BMC pregnancy and childbirth·2026
Same author

Sex differences in the use of blood pressure lowering therapy and blood pressure control.

Journal of hypertension·2026
Same author

COVID-19 vaccination and short-term mortality risk: a nationwide self-controlled case series study in The Netherlands.

European journal of epidemiology·2026
Same author

Cohort event monitoring of booster COVID-19 vaccine safety using patient-reported outcomes in pregnant women.

Frontiers in drug safety and regulation·2026

Atorvastatin significantly reduced cardiovascular and cerebrovascular events compared to other statins. This finding highlights atorvastatin

Area of Science:

  • Cardiovascular Medicine
  • Pharmacology
  • Epidemiology

Background:

  • Statins are widely used for cardiovascular disease prevention.
  • Previous studies primarily focused on surrogate endpoints.
  • Limited research exists on clinical event differences among statins.

Purpose of the Study:

  • To compare the risk of cardiovascular and cerebrovascular events between atorvastatin users and other statin users.
  • To evaluate clinical endpoint differences in a general practice setting.

Main Methods:

  • A cohort study utilizing the Integrated Primary Care Information project database in The Netherlands.
  • Inclusion of new statin users between September 1999 and December 2002.
  • Multivariate Cox-regression analysis to compare primary endpoints.

Related Experiment Videos

Main Results:

  • 3499 new statin users were analyzed, with a median follow-up of 1.9 years.
  • Atorvastatin users showed a significantly lower risk of cardiovascular and cerebrovascular events (RR: 0.70, 95% CI: 0.55-0.96).
  • The protective effect was more pronounced in patients without a prior history of cardiovascular events.

Conclusions:

  • Atorvastatin demonstrated a more favorable effect on cardiovascular and cerebrovascular events compared to other statins in the general population.
  • These findings support atorvastatin's efficacy in preventing major clinical events.